Target intelligence / Profile preview

Reactive oxygen species-mediated cytotoxicity

Molecular classification
Other
01

Overview

Reactive oxygen species-mediated cytotoxicity is a process by which elevated levels of reactive oxygen species (ROS)—such as superoxide, hydrogen peroxide, hydroxyl radical, and singlet oxygen—induce cellular damage and death. ROS are byproducts of normal cellular metabolism but can accumulate to toxic levels during cellular stress or exposure to certain drugs. This oxidative stress leads to damage of DNA, proteins, and lipids, resulting in apoptosis, necrosis, or autophagy[1][3]. Multiple anti-cancer drugs work in part by increasing intracellular ROS, pushing cancer cells beyond their antioxidant capacity, thereby inducing programmed or unregulated cell death. While this process can be therapeutically beneficial for eliminating cancerous or infected cells, excessive ROS can also damage healthy tissue and contribute to a wide range of pathological conditions, including cancer, cardiovascular, neurodegenerative, and inflammatory diseases[1][3][4]. In summary, "reactive oxygen species-mediated cytotoxicity" is *not* a molecular target but a cytotoxic mechanism involving numerous molecules and pathways; as such, it does not map to a canonical target required by drug discovery databases.

Other names
ROS-mediated cytotoxicityoxidative stress-induced cell deathROS-induced cytotoxicity
02

Mechanism of action

Induction of oxidative stress leading to apoptosis or necrosis; Disruption of mitochondrial membrane potential; DNA damage via ROS; Lipid peroxidation; Protein oxidation (These mechanisms outline how drugs exploit ROS-mediated cytotoxicity[1][4].)

03

Biological functions

Cell deathApoptosisNecrosisAutophagyImmune responseSignal transduction
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseInfectionOther
05

Safety considerations

Off-target tissue damage due to oxidative stressCardiotoxicity (as seen with doxorubicin)NeurotoxicityInflammationRisk of secondary malignancies
06

Interacting drugs

Doxorubicin

3 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA; marker of lipid peroxidation)8-oxoguanine (marker of DNA oxidation)Reduced glutathione (GSH) / oxidized glutathione (GSSG) ratioSuperoxide dismutase (SOD) activityCatalase activity

Beyond the preview

Go deeper on Reactive oxygen species-mediated cytotoxicity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species-mediated cytotoxicity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call